Astrazeneca Phar

Part of MojoOne Strategy

Market Cap: Large Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE203A01020
NSEID: ASTRAZEN
BSEID: 506820

INR

8,388.95

385.05 (4.81%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 18.23 k

Click here to access the older version

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Rs cr

Standalone Quarterly Results

Dec'24

Sep'24

Jun'24

Mar'24

Dec'23

Sep'23

Jun'23

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2024 is 7.91% vs 5.28% in Sep 2024

Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -19.72% vs 425.95% in Sep 2024

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2024 is 46.54% vs 38.01% in Sep 2024

Interest

QoQ Growth in quarter ended Dec 2024 is -2.94% vs 209.09% in Sep 2024

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

Compare Quarterly Results Of Astrazeneca Phar With

Select Peers

Figures in Rs cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

440.29

2,396.57

-1,956.28

-81.63%

Other Operating Income

0.00

Total Operating income

440.29

2,396.57

-1,956.28

-81.63%

Raw Material Cost

69.88

179.72

-109.84

-61.12%

Purchase of Finished goods

228.76

445.60

-216.84

-48.66%

(Increase) / Decrease In Stocks

-51.61

34.08

-85.69

-251.44%

Employee Cost

62.37

521.79

-459.42

-88.05%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

22.74

0.00

22.74

Other Expenses

31.16

474.45

-443.29

-93.43%

Total Expenditure (Excl Depreciation)

363.30

1,655.64

-1,292.34

-78.06%

Operating Profit (PBDIT) excl Other Income

76.99

740.93

-663.94

-89.61%

Other Income

7.98

69.82

-61.84

-88.57%

Operating Profit (PBDIT)

84.97

810.75

-725.78

-89.52%

Interest

0.33

199.47

-199.14

-99.83%

Exceptional Items

-33.55

0.00

-33.55

Gross Profit (PBDT)

51.09

611.28

-560.19

-91.64%

Depreciation

9.07

87.03

-77.96

-89.58%

Profit Before Tax

42.02

524.25

-482.23

-91.98%

Tax

11.17

107.87

-96.70

-89.64%

Provisions and contingencies

0.00

Profit After Tax

30.85

416.38

-385.53

-92.59%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

30.85

416.38

-385.53

-92.59%

Equity Capital

5.00

40.06

-35.06

-87.52%

Face Value

2.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

12.34

10.39

1.95

18.77%

Diluted Earnings per share

12.34

10.33

2.01

19.46%

Operating Profit Margin (Excl OI)

17.49%

30.92%

0.00

-13.43%

Gross Profit Margin

11.60%

25.51%

0.00

-13.91%

PAT Margin

7.01%

17.37%

0.00

-10.36%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 440.29 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 7.91% vs 5.28% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 43.98% vs 22.41% in Dec 2023

Quarterly - Standalone Net Profit

Standalone Net Profit 30.85 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -19.72% vs 425.95% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 95.25% vs -46.08% in Dec 2023

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 76.99 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 46.54% vs 38.01% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 411.56% vs -58.87% in Dec 2023

Quarterly - Interest

Interest 0.33 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -2.94% vs 209.09% in Sep 2024

YoY Growth in quarter ended Dec 2024 is -45.90% vs 205.00% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 17.49%

in Dec 2024

Figures in Rs %

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023